Menopause leading to increased vaginal wall thickness in women with genital prolapse: Impact on sexual response

Journal of Sexual Medicine

Volumn 6, Issue 11, 2009, Pages 3097-3110

  Da Silva Lara, Lúcia Alves ^a   Da Silva, Alfredo Ribeiro ^a   Rosa e Silva, Júlio César ^a   Chaud, Fernando ^a   Silva de Sá, Marcos Felipe ^a   Meireles e Silva, Antônio Renato ^a   De Sá Rosa e Silva, Ana Carolina Japur ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dyspareunia; Hypoestrogenism; Morphometry; Sexual dysfunction; Vagina; Vagina wall

Indexed keywords

ESTRADIOL; FOLLITROPIN; GLUCOSE; PROLACTIN; THYROTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; STAINING; THICKNESS; THYROTROPIN BLOOD LEVEL; UTERUS PROLAPSE; VAGINA EPITHELIUM; VAGINAL WALL THICKNESS;

EID: 70749085946     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01407.x     Document Type: Article

References (103)

1. Basaran M, Kosif R, Bayar U, Civelek B. Characteristics of external genitalia in pre- and postmenopausal women. Climacteric 2008, 11:416-21.
2. Lara LA, Useche B, Ferriani RA, Reis RM, de Sá MF, de Freitas MM, Rosa e Silva JC, Rosa e Silva AC. The effects of hypoestrogenism on the vaginal wall: Interference with the normal sexual response. J Sex Med 2009, 6:30-9.
3. Hsu Y, Chen L, Delancey JO, Ashton-Miller JA. Vaginal thickness, cross-sectional area, and perimeter in women with and those without prolapse. Obstet Gynecol 2005, 105:1012-7.
4. Boreham MK, Wai CY, Miller RT, Schaffer JI, Word RA. Morphometric properties of the posterior vaginal wall in women with pelvic organ prolapse. Am J Obstet Gynecol 2002, 187:1501-8. discussion 1508-9
5. Alatas E, Yagci B, Oztekin O, Sabir N. Effect of hormone replacement therapy on clitoral artery blood flow in healthy postmenopausal women. J Sex Med 2008, 10:10.
6. Blakeman PJ, Hilton P, Bulmer JN. Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Inter 2000, 86:32-8.
7. Cunha GR, Ricke W, Thomson A, Marker PC, Risbridger G, Hayward SW, Wang YZ, Donjacour AA, Kurita T. Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. J Steroid Biochem Mol Biol 2004, 92:221-36.
8. Buchanan DL, Kurita T, Taylor JA, Lubahn DB, Cunha GR, Cooke PS. Role of stromal and epithelial estrogen receptors in vaginal epithelial proliferation, stratification, and cornification. Endocrinology 1998, 139:4345-52.
9. Buchanan DL, Setiawan T, Lubahn DB, Taylor J, Kurita T, Cunha GR, Cooke PS. Tissue compartment-specific estrogen receptor-alpha participation in the mouse uterine epithelial secretory response. Endocrinology 1999, 140:484-91.
10. Berman JR, McCarthy MM, Kyprianou N. Effect of estrogen withdrawal on nitric oxide synthase expression and apoptosis in the rat vagina. Urology 1998, 51:650-6.
11. Fadiel A, Lee HH, Demir N, Richman S, Iwasaki A, Connell K, Naftolin F. Ezrin is a key element in the human vagina. Maturitas 2008, 60:31-41.
12. Soderberg MW, Johansson B, Masironi B, Bystrom B, Falconer C, Sahlin L, Ordeberg GE. Pelvic floor sex steroid hormone receptors, distribution and expression in pre- and postmenopausal stress urinary incontinent women. Acta Obstet Gynecol Scand 2007, 86:1377-84.
13. Bochicchio B, Pepe A, Tamburro AM. Investigating by CD the molecular mechanism of elasticity of elastomeric proteins. Chirality 2008, 21:21.
14. Nappi RE, Polatti F. The use of estrogen therapy in women's sexual functioning (CME). J Sex Med 2009, 6:603-16. quiz 618-609.
15. Ottesen B, Fahrenkrug J. Vasoactive intestinal polypeptide and other preprovasoactive intestinal polypeptide-derived peptides in the female and male genital tract: Localization, biosynthesis, and functional and clinical significance. Am J Obstet Gynecol 1995, 172:1615-31.
16. Zicari A, Centonze C, Realacci M, Buchetti B, Pietropolli A, Ticconi C. Estradiol 17-beta and progesterone modulate inducible nitric oxide synthase and high mobility group box 1 expression in human endometrium. Reprod Sci 2008, 15:559-66.
17. Levin RJ. The physiology of sexual arousal in the human female: A recreational and procreational synthesis. Arch Sex Behav 2002, 31:405-11.
18. Levin RJ, Wylie K. Vaginal vasomotion-Its appearance, measurement, and usefulness in assessing the mechanisms of vasodilatation. J Sex Med 2008, 5:377-86.
19. Levine KB, Williams RE, Hartmann KE. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause (New York, NY) 2008, 9:9.
20. Clobes A, DeLancey JO, Morgan DM. Urethral circular smooth muscle in young and old women. Am J Obstet Gynecol 2008, 198:587.
21. Ting AY, Blacklock AD, Smith PG. Estrogen regulates vaginal sensory and autonomic nerve density in the rat. Biol Reprod 2004, 71:1397-404.
22. Resplande J, Gholami SS, Graziottin TM, Rogers R, Lin CS, Leng W, Lue TF. Long-term effect of ovariectomy and simulated birth trauma on the lower urinary tract of female rats. J Urol 2002, 168:323-30.
23. Bachmann GA, Leiblum SR. The impact of hormones on menopausal sexuality: A literature review. Menopause (New York, NY) 2004, 11:120-30.
24. Nilsson K, Risberg B, Heimer G. The vaginal epithelium in the postmenopause-cytology, histology and pH as methods of assessment. Maturitas 1995, 21:51-6.
25. Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, Spino C, Whitehead WE, Wu J, Brody DJ. Prevalence of symptomatic pelvic floor disorders in US women. JAMA 2008, 300:1311-6.
26. Hoyle CH, Stones RW, Robson T, Whitley K, Burnstock G. Innervation of vasculature and microvasculature of the human vagina by NOS and neuropeptide-containing nerves. J Anat 1996, 188:633-44.
27. Bahamondes L, Trevisan M, Andrade L, Marchi NM, Castro S, Diaz J, Faundes A. The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera. Contraception 2000, 62:23-7.
28. Tulikangas PK, Walters MD, Brainard JA, Weber AM. Enterocele: Is there a histologic defect?. Obstet Gynecol 2001, 98:634-7.
29. Baden WF, Walker TA. Physical diagnosis in the evaluation of vaginal relaxation. Clin Obstet Gynecol 1972, 15:1055-69.
30. Rust J, Golombok S. The Golombok-Rust Inventory of Sexual Satisfaction (GRISS). Br J Clin Psychol 1985, 24:63-4.
31. van Lankveld JJ, van Koeveringe GA. Predictive validity of the Golombok Rust Inventory of Sexual Satisfaction (GRISS) for the presence of sexual dysfunctions within a Dutch urological population. Int J Impot Res 2003, 15:110-6.
32. Rust J, Golombok SRJ. The handbook of Golombok Rust inventory of sexual satisfaction 1986, NFER-Nelson, Windsor
33. Deval B, Rafii A, Poilpot S, Aflack N, Levardon M. Prolapse in the young woman: Study of risk factors. Gynecol Obstet Fertil 2002, 30:673-6.
34. Tegerstedt G, Miedel A, Maehle-Schmidt M, Nyren O, Hammarstrom M. Obstetric risk factors for symptomatic prolapse: A population-based approach. Am J Obstet Gynecol 2006, 194:75-81.
35. Gomman HM, Nossier SA, Fotohi EM, Kholeif AE. Prevalence and factors associated with genital prolapse: A hospital-based study in Alexandria (Part I). J Egypt Public Health Assoc 2001, 76:313-35.
36. Trowbridge ER, Fultz NH, Patel DA, DeLancey JO, Fenner DE. Distribution of pelvic organ support measures in a population-based sample of middle-aged, community-dwelling African American and white women in southeastern Michigan. Am J Obstet Gynecol 2008, 198:548.
37. Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: Prevalence and correlates. Obstet Gynecol 2008, 112:970-8.
38. Hong L, Wu K, Fan D. Sildenafil as treatment for antidepressant-induced sexual dysfunction. JAMA 2008, 300:2365. author reply 2365-6
39. Leiblum S, Seehuus M, Goldmeier D, Brown C. Psychological, medical, and pharmacological correlates of persistent genital arousal disorder. J Sex Med 2007, 4:1358-66.
40. Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med 2007, 4:917-29.
41. Kim CM, Jeon MJ, Chung DJ, Kim SK, Kim JW, Bai SW. Risk factors for pelvic organ prolapse. Int J Gynaecol Obstet 2007, 98:248-51.
42. Tan JS, Lukacz ES, Menefee SA, Luber KM, Albo ME, Nager CW. Determinants of vaginal length. Am J Obstet Gynecol 2006, 195:1846-50.
43. Borges LF, Gutierrez PS, Marana HR, Taboga SR. Picrosirius-polarization staining method as an efficient histopathological tool for collagenolysis detection in vesical prolapse lesions. Micron 2007, 38:580-3.
44. Weber AM, Walters MD, Piedmonte MR. Sexual function and vaginal anatomy in women before and after surgery for pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol 2000, 182:1610-5.
45. Kim NN, Min K, Pessina MA, Munarriz R, Goldstein I, Traish AM. Effects of ovariectomy and steroid hormones on vaginal smooth muscle contractility. Int J Impot Res 2004, 16:43-50.
46. Pessina MA, Hoyt RF, Goldstein I, Traish AM. Differential effects of estradiol, progesterone, and testosterone on vaginal structural integrity. Endocrinology 2006, 147:61-9.
47. Hilliges M, Falconer C, Ekman-Ordeberg G, Johansson O. Innervation of the human vaginal mucosa as revealed by PGP 9.5 immunohistochemistry. Acta Anat 1995, 153:119-26.
48. Pauls R, Mutema G, Segal J, Silva WA, Kleeman S, Dryfhout Ma V, Karram M. A prospective study examining the anatomic distribution of nerve density in the human vagina. J Sex Med 2006, 3:979-87.
49. Gravina GL, Brandetti F, Martini P, Carosa E, Di Stasi SM, Morano S, Lenzi A, Jannini EA. Measurement of the thickness of the urethrovaginal space in women with or without vaginal orgasm. J Sex Med 2008, 5:610-8.
50. Greendale GA, Lee NP, Arriola ER. The menopause. Lancet 1999, 353:571-80.
51. Leiblum S, Bachmann G, Kemmann E, Colburn D, Swartzman L. Vaginal atrophy in the postmenopausal woman. The importance of sexual activity and hormones. JAMA 1983, 249:2195-8.
52. Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 2000, 61:3090-6.
53. Schild C, Trueb B. Mechanical stress is required for high-level expression of connective tissue growth factor. Exp Cell Res 2002, 274:83-91.
54. Takacs P, Gualtieri M, Nassiri M, Candiotti K, Medina CA. Vaginal smooth muscle cell apoptosis is increased in women with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2008, 2:2.
55. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science (New York, NY) 1995, 267:1456-62.
56. Bovin LF, Bendtzen K. Apoptosis-Programmed cell death. Ugeskr Laeger 1999, 161:5778-82.
57. Boreham MK, Wai CY, Miller RT, Schaffer JI, Word RA. Morphometric analysis of smooth muscle in the anterior vaginal wall of women with pelvic organ prolapse. Am J Obstet Gynecol 2002, 187:56-63.
58. Roy S, Caillouette JC, Roy T, Faden JS. Vaginal pH is similar to follicle-stimulating hormone for menopause diagnosis. Am J Obstet Gynecol 2004, 190:1272-7.
59. Das S, Sabin C, Allan S. Higher vaginal pH is associated with Chlamydia trachomatis infection in women: A prospective case-controlled study. Int J STD AIDS 2005, 16:290-3.
60. Goldstein I, Alexander JL. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. J Sex Med 2005, 2(3):154-65. suppl
61. Owen MK, Clenney TL. Management of vaginitis. Am Fam Physician 2004, 70:2125-32.
62. Bachmann G. Urogenital ageing: An old problem newly recognized. Maturitas 1995, 22:S1-5. suppl
63. Cotreau MM, Chennathukuzhi VM, Harris HA, Han L, Dorner AJ, Apseloff G, Varadarajan U, Hatstat E, Zakaria M, Strahs AL, Crabtree JS, Winneker RC, Jelinsky SA. A study of 17beta-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy. Maturitas 2007, 8:8.
64. Pivarcsi A, Nagy I, Koreck A, Kis K, Kenderessy-Szabo A, Szell M, Dobozy A, Kemeny L. Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human beta-defensin-2 in vaginal epithelial cells. Microbes Infect 2005, 7:1117-27.
65. Kummer S, Hayes GR, Gilbert RO, Beach DH, Lucas JJ, Singh BN. Induction of human host cell apoptosis by Trichomonas vaginalis cysteine proteases is modulated by parasite exposure to iron. Microb Pathog 2008, 44:197-203.
66. Gasparoto TH, Gaziri LC, Burger E, de Almeida RS, Felipe I. Apoptosis of phagocytic cells induced by Candida albicans and production of IL-10. FEMS Immunol Med Microbiol 2004, 42:219-24.
67. Chen L, Ashton-Miller JA, Hsu Y, DeLancey JO. Interaction among apical support, levator ani impairment, and anterior vaginal wall prolapse. Obstet Gynecol 2006, 108:324-32.
68. Swartz MA, Tschumperlin DJ, Kamm RD, Drazen JM. Mechanical stress is communicated between different cell types to elicit matrix remodeling. Proc Natl Acad Sci USA 2001, 98:6180-5.
69. Chuang Y, Chuang W, Huang C. Myocyte apoptosis in the pathogenesis of ureteral damage in rats with obstructive uropathy. Urology 2001, 58:463-70.
70. Siddiqui S, Martin JG. Structural aspects of airway remodeling in asthma. Curr Allergy Asthma Rep 2008, 8:540-7.
71. Kim J, Zhang L, Peppel K, Wu JH, Zidar DA, Brian L, DeWire SM, Exum ST, Lefkowitz RJ, Freedman NJ. Beta-arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migration. Circ Res 2008, 103:70-9.
72. Billig H, Furuta I, Hsueh AJ. Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology 1993, 133:2204-12.
73. Kyprianou N, English HF, Davidson NE, Isaacs JT. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 1991, 51:162-6.
74. Drewett N, Jacobi JM, Willgoss DA, Lloyd HM. Apoptosis in the anterior pituitary gland of the rat: Studies with estrogen and bromocriptine. Neuroendocrinology 1993, 57:89-95.
75. Helpman L, Greenstein A, Hartoov J, Abramov L. Genito-sensory analysis in women with arousal and orgasmic dysfunction. J Sex Med 2009, 4:4.
76. Abdo CH, Oliveira WM, Moreira ED, Fittipaldi JA. Prevalence of sexual dysfunctions and correlated conditions in a sample of Brazilian women-results of the Brazilian study on sexual behavior (BSSB). Int J Impot Res 2004, 16:160-6.
77. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999, 281:537-44.
78. Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive sexual desire disorder in menopausal women: A survey of Western European women. J Sex Med 2006, 3:212-22.
79. Dennerstein L, Alexander JL, Kotz K. The menopause and sexual functioning: A review of the population-based studies. Annu Rev Sex Res 2003, 14:64-82.
80. Dalpiaz O, Kerschbaumer A, Mitterberger M, Pinggera GM, Colleselli D, Bartsch G, Strasser H. Female sexual dysfunction: A new urogynaecological research field. BJU Int 2008, 101:717-21.
81. Achtari C, Dwyer PL. Sexual function and pelvic floor disorders. Best Pract Res Clin Obstet Gynaecol 2005, 19:993-1008. quiz A1001-1008
82. Yip SK, Chan A, Pang S, Leung P, Tang C, Shek D, Chung T. The impact of urodynamic stress incontinence and detrusor overactivity on marital relationship and sexual function. Am J Obstet Gynecol 2003, 188:1244-8.
83. Ellerkmann RM, Cundiff GW, Melick CF, Nihira MA, Leffler K, Bent AE. Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol 2001, 185:1332-7. discussion 1337-8
84. Song SH, Jeon H, Kim SW, Paick JS, Son H. The prevalence and risk factors of female sexual dysfunction in young Korean women: An internet-based survey. J Sex Med 2008, 5:1694-701.
85. Safarinejad MR. Female sexual dysfunction in a population-based study in Iran: Prevalence and associated risk factors. Int J Impot Res 2006, 18:382-95.
86. Dennerstein L, Randolph J, Taffe J, Dudley E, Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil steril 2002, 77(4):S42-8. suppl
87. Burger H. The menopausal transition. Baillieres Clin Obstet Gynaecol 1996, 10:347-59.
88. Groeneveld FP, Bareman FP, Barentsen R, Dokter HJ, Drogendijk AC, Hoes AW. The climacteric and well-being. J Psychosom Obstet Gynaecol 1993, 14:127-43.
89. Fernandez Hernandez M, Gaviria Cano MN, Munoz Gonzalez F, Miguel Calvo I, Coll Torres E, Fuentes Ferrer ME. Sexuality in older women. Aten Primaria 2006, 37:504-9.
90. Moreira ED, Kim SC, Glasser D, Gingell C. Sexual activity, prevalence of sexual problems, and associated help-seeking patterns in men and women aged 40-80 years in Korea: Data from the Global Study of Sexual Attitudes and Behaviors (GSSAB). J Sex Med 2006, 3:201-11.
91. Gallicchio L, Schilling C, Tomic D, Miller SR, Zacur H, Flaws JA. Correlates of sexual functioning among mid-life women. Climacteric 2007, 10:132-42.
92. Graziottin A. Prevalence and evaluation of sexual health problems-HSDD in Europe. J Sex Med 2007, 4(3):211-9. suppl
93. Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J, Goldstein I, Graziottin A, Heiman J, Laan E, Leiblum S, Padma-Nathan H, Rosen R, Segraves K, Segraves RT, Shabsigh R, Sipski M, Wagner G, Whipple B. Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications. J Urol 2000, 163:888-93.
94. Hayes RD, Bennett CM, Fairley CK, Dennerstein L. What can prevalence studies tell us about female sexual difficulty and dysfunction?. J Sex Med 2006, 3:589-95.
95. Garcia S, Moreno S, Aponte H. Prevalence of sexual dysfunction in female outpatients and personnel at a Colombian hospital: Correlation with hormonal profile. J Sex Med 2008, 5:1208-13.
96. Dunn KM, Jordan K, Croft PR, Assendelft WJ. Systematic review of sexual problems: Epidemiology and methodology. J Sex Marital Ther 2002, 28:399-422.
97. Hayes RD, Dennerstein L, Bennett CM, Fairley CK. What is the " true" prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact?. J Sex Med 2008, 5:777-87.
98. Hayes RD, Dennerstein L, Bennett CM, Fairley CK. Risk factors for female sexual dysfunction in the general population: Exploring factors associated with low sexual function and sexual distress. J Sex Med 2008, 11:11.
99. Heiman JR, Guess MK, Connell K, Melman A, Hyde JS, Segraves RT, Wyllie MG. Standards for clinical trials in sexual dysfunctions of women: Research designs and outcomes assessment. J Sex Med 2004, 1:92-7.
100. Fisher H, Aron A, Brown LL. Romantic love: An fMRI study of a neural mechanism for mate choice. J Comp Neurol 2005, 493:58-62.
101. Dennerstein L, Lehert P, Burger H. The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition. Fertil Steril 2005, 84:174-80.
102. Howard JR, O'Neill S, Travers C. Factors affecting sexuality in older Australian women: Sexual interest, sexual arousal, relationships and sexual distress in older Australian women. Climacteric 2006, 9:355-67.
103. Basson R. Hormones and sexuality: Current complexities and future directions. Maturitas 2007, 57:66-70.